Cargando…

The natural history of, and risk factors for, progressive Chronic Kidney Disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol

BACKGROUND: Chronic kidney disease (CKD) affects up to 16% of the adult population and is associated with significant morbidity and mortality. People at highest risk from progressive CKD are defined by a sustained decline in estimated glomerular filtration rate (eGFR) and/or the presence of signific...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stringer, Stephanie, Sharma, Praveen, Dutton, Mary, Jesky, Mark, Ng, Khai, Kaur, Okdeep, Chapple, Iain, Dietrich, Thomas, Ferro, Charles, Cockwell, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664075/ https://www.ncbi.nlm.nih.gov/pubmed/23617441 http://dx.doi.org/10.1186/1471-2369-14-95

Ejemplares similares

Allopurinol Is an Independent Determinant of Improved Arterial Stiffness in Chronic Kidney Disease: A Cross-Sectional Study
por: Ng, Khai P., et al.
Publicado: (2014)

INfluence of Successful Periodontal Intervention in REnal Disease (INSPIRED): study protocol for a randomised controlled pilot clinical trial
por: Sharma, Praveen, et al.
Publicado: (2017)

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study
por: Jesky, Mark D., et al.
Publicado: (2016)

Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease
por: Fenton, Anthony, et al.
Publicado: (2018)

Association between periodontitis and mortality in stages 3–5 chronic kidney disease: NHANES III and linked mortality study
por: Sharma, Praveen, et al.
Publicado: (2016)

Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
por: Norris, Keith C., et al.
Publicado: (2019)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU
por: Brothwell, Shona, et al.
Publicado: (2013)

Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial
por: Ng, Khai P, et al.
Publicado: (2014)

The impact of chronic kidney disease and cardiovascular comorbidity on mortality in a multiethnic population: a retrospective cohort study
por: Jesky, Mark, et al.
Publicado: (2013)

Methods and rationale of the DISCOVER CKD global observational study
por: Pecoits-Filho, Roberto, et al.
Publicado: (2021)

Incidence and impact on outcomes of acute kidney injury after a stroke: a systematic review and meta-analysis
por: Arnold, Julia, et al.
Publicado: (2018)

Hispanic Secondary Stroke Prevention Initiative Design: Study Protocol and Rationale for a Randomized Controlled Trial
por: Carrasquillo, Olveen, et al.
Publicado: (2018)

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease
por: Fenton, Anthony, et al.
Publicado: (2017)

Imbalanced turnover of collagen type III is associated with disease progression and mortality in high-risk chronic kidney disease patients
por: Genovese, Federica, et al.
Publicado: (2020)

Cognitive Impairment in Diabetes: Rationale and Design Protocol of the Cog-ID Study
por: Koekkoek, Paula S, et al.
Publicado: (2015)

KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methods
por: Kang, Hee Gyung, et al.
Publicado: (2016)

Concordance of three point of care testing devices with clinical chemistry laboratory standard assays and patient-reported outcomes of blood sampling methods
por: Yonel, Z., et al.
Publicado: (2022)

Oxidative stress links periodontal inflammation and renal function
por: Sharma, Praveen, et al.
Publicado: (2021)

Urinary endotrophin predicts disease progression in patients with chronic kidney disease
por: Rasmussen, Daniel Guldager Kring, et al.
Publicado: (2017)

A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease
por: Holm Nielsen, Signe, et al.
Publicado: (2018)

The Preserving Kidney Function in Children With CKD (PRESERVE) Study: Rationale, Design, and Methods
por: Denburg, Michelle R., et al.
Publicado: (2023)

Rationale, design, and baseline features of a randomized controlled trial to assess the effects of statin for the secondary prevention of stroke: the Japan Statin Treatment Against Recurrent Stroke (J-STARS)
por: Nagai, Yoji, et al.
Publicado: (2014)

The Nigerian national blindness and visual impairment survey: Rationale, objectives and detailed methodology
por: Dineen, Brendan, et al.
Publicado: (2008)

Results and lessons from the Spironolactone To Prevent Cardiovascular Events in Early Stage Chronic Kidney Disease (STOP-CKD) randomised controlled trial
por: Ng, Khai P, et al.
Publicado: (2016)

Predicting Appropriate Admission of Bronchiolitis Patients in the Emergency Department: Rationale and Methods
por: Luo, Gang, et al.
Publicado: (2016)

Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) Study
por: Moulson, Nathaniel, et al.
Publicado: (2023)

Sedentary Behaviour Intervention as a Personalised Secondary Prevention Strategy (SIT LESS) for patients with coronary artery disease participating in cardiac rehabilitation: rationale and design of the SIT LESS randomised clinical trial
por: van Bakel, B M A, et al.
Publicado: (2022)

Characteristics of COVID-19 patients with preexisting CKD history
por: Xu, Chuou, et al.
Publicado: (2021)

The effect of magnesium supplementation on vascular calcification in chronic kidney disease—a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale
por: Bressendorff, Iain, et al.
Publicado: (2017)

CARbon DIoxide for the treatment of Febrile seizures: rationale, feasibility, and design of the CARDIF-study
por: Ohlraun, Stephanie, et al.
Publicado: (2013)

Processes, contexts, and rationale for disinvestment: a protocol for a critical interpretive synthesis
por: Wilson, Michael G, et al.
Publicado: (2014)

A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial
por: Hayer, Manvir K., et al.
Publicado: (2017)

The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results
por: Pattaro, Cristian, et al.
Publicado: (2015)

Combined Dietary Nitrate and Exercise Intervention in Peripheral Artery Disease: Protocol Rationale and Design
por: Woessner, Mary N, et al.
Publicado: (2017)

Shuxuetong for Prevention of recurrence in Acute Cerebrovascular events with Embolism (SPACE) trial: rationale and design
por: Gu, Hong-Qiu, et al.
Publicado: (2020)

China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design
por: Liu, Liping, et al.
Publicado: (2021)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Rationales, design and recruitment for the Elfe longitudinal study
por: Vandentorren, Stéphanie, et al.
Publicado: (2009)

Rationales, design and recruitment of the Taizhou Longitudinal Study
por: Wang, Xiaofeng, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_t3oobf6eb6cr0oce8ptct12jrc